Aria CV, Inc: Improving the lives of patients suffering from the disease of pulmonary hypertension.
Location: United States, Minnesota, Saint Paul
Employees: 11-50
Total raised: $31M
Founded date: 2010
Investors 5
| Date | Name | Website |
| - | Gravity Fu... | gravityfun... |
| - | KOFA Healt... | kofahealth... |
| - | Angel Phys... | angelphysi... |
| - | BioStar Ca... | biostar.ca... |
| - | Catalyst H... | chv.vc |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 26.02.2020 | Series B | $31M | - |
Mentions in press and media 9
| Date | Title | Description |
| 20.07.2022 | Aria CV raises $13 million bridge round to further develop heart implant | - |
| 11.08.2021 | Meet Josh Phillips and Darshana Zaveri, managing partners at Catalyst Health Ventures | CHV invests exclusively in seed, Series A and Series B companies in the medtech space Venture capital used to be a cottage industry, with very few investing in tomorrow's products and services. Oh, how times have changed! While there are mo... |
| 27.02.2020 | Malaysia’s Xeraya Capital leads $31m Series B round for US medical device maker Aria CV | Premium Malaysian private equity firm Xeraya Capital has led the $31-million Series B round of financing in US-based developer of medical devices Aria CV Inc, according to a press statement. Continue reading this story with a subscription t... |
| 26.02.2020 | Aria CV nets $31M to support first US clinical study of its implant | “This will be the first implant for the treatment of pulmonary arterial hypertension,” said Gladney, an early investor in Aria CV who has been its CEO since April. He had previously been on the company’s board. The implant – known as the Ar... |
| 25.02.2020 | Aria CV Raises $31M in Series B Funding | Aria CV, Inc., a St. Paul, Minn.-based developer of medical devices treating Pulmonary Arterial Hypertension (PAH), completed a $31m Series B round of financing. The round was led by Xeraya Capital, with participation from Longview Ventures... |
| 25.02.2020 | Aria CV Receives $31M Series B Funding | ST. PAUL, MN, Aria CV today announced that it has completed a $31 million Series B round of financing to fund its first clinical study in the United States. >> Click here for more funding data on Aria CV >> To export Aria CV... |
| 14.10.2019 | Top 10 VCs investing in medical device companies | They include NEA, Versant Ventures, SOSV and Innova Memphis Healthtech is a big and broad space, so much so that there are whole subsectors that see more investments than entire industries. Medical device companies, for example, raised $2.9... |
| - | Aria CV nets $31M to support first US clinical study of its implant | Aria CV has landed $31 million in Series B funding that will support the first clinical study in the U.S. of the company’s lead device, which the company hopes to commercialize in 2023. The device is designed to be implanted permanently in ... |
| - | Manage your consent preferences Aria CV raises $13 million bridge round to further develop heart implant | - |